Free Trial

PaxMedica (PXMD) Insider Trading & Ownership

PaxMedica logo
$0.10 0.00 (0.00%)
(As of 11/20/2024 ET)

PaxMedica (NASDAQ:PXMD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$581.93
Get PXMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling PaxMedica stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PXMD Insider Buying and Selling by Quarter

PaxMedica Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/29/2024Howard J WeismanCEOSell372$0.47$174.84  
1/29/2024Karen LarochelleDirectorSell78$0.48$37.44  
11/27/2023Howard J WeismanCEOSell162$1.03$166.86  
11/27/2023John F CoelhoDirectorSell12$1.02$12.24  
11/27/2023Michael DerbyMajor ShareholderSell185$1.03$190.55  
(Data available from 1/1/2013 forward)

PXMD Insider Trading Activity - Frequently Asked Questions

The list of insiders at PaxMedica includes Howard J Weisman, John F Coelho, Karen Larochelle, Michael Derby, and Zachary Rome. Learn more on insiders at PXMD.

1.00% of PaxMedica stock is owned by insiders. Learn more on PXMD's insider holdings.

The following insiders have sold PXMD shares in the last 24 months: Howard J Weisman ($111,180.51), John F Coelho ($6,217.41), Karen Larochelle ($515.48), Michael Derby ($52,538.99), and Zachary Rome ($109,314.42).

Insiders have sold a total of 15,190 PaxMedica shares in the last 24 months for a total of $279,766.81 sold.

PaxMedica Key Executives

  • Mr. Howard J. Weisman (Age 64)
    CEO & Chairman
    Compensation: $717.2k
  • Mr. Stephen Douglas Sheldon (Age 44)
    CFO & COO
    Compensation: $450.85k
  • Dr. David W. Hough M.D. (Age 66)
    Chief Medical Officer
    Compensation: $87.5k


This page (NASDAQ:PXMD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners